openPR Logo
Press release

Lung Cancer and Therapies Meet 2019

11-12-2018 07:32 PM CET | Health & Medicine

Press release from: Lexis Conferences

Lexis is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products.
It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques to treat Lung Cancer with different approach. This meet enlightens the latest treatment advancements in Lung Cancer and the researchers around the globe who concentrates on growth about ongoing advances like first stage analysis to treatment etc., this is the best chance to achieve the biggest array of members.
This conference invites Oncologists, Academicians, Physicians, Academic scientists, Radiologists, Chemo therapists, Industry professionals, Head of the departments, Directors, Clinical Professionals, Young researchers, Postgraduates, Trainees and above all Lung cancer Researchers. It also gives the best opportunity to the Business professionals to represent their company.
Lung Cancer Therapies Meet 2019 cordially conducted by the Lexis in Berlin, Germany on May 17-18, 2019 mainly focuses on cause and cure for the Lung Cancer which is the second major cancer causing death to the people around the world. The congress runs with the theme “Interchanging the Scientific Enlightenment about Lung Diseases and Research”.
For more details please follow: www.lexisconferences.com/lungcancer
Further queries please feel free to contact us

Thanks & Regards
Sarah Williams
Program Director | Euro Lung Cancer 2019
E: lungcancer@lexisevent.com
4211 Rainier Street, Irving
Texas 75062, USA | T: +1 (214) 972-2216
|||||Lexis

Lexis with the indomitable aim of transforming the fields of Science, Technology and Healthcare, Lexis matches our unshakeable service ethos to the most skilled and enthusiastic professionals. Through our expertise in publishing, event and association management, our goal is to support the scientific communities and networks, as we combine to propel science and health into the future. Lexis believes in integrating innovation with the latest research to remain the preeminent event organizer

4211 Rainier Street, Irving
Texas 75062, USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer and Therapies Meet 2019 here

News-ID: 1359057 • Views: 202

More Releases from Lexis Conferences

Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Human Physiology 2019
Human Physiology 2019 Theme: Exploring the Principles of Physiology & Metabolism September 16-17, 2019 | London, United Kingdom Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build
Global Conference on Mechanical, Automotive and Materials Engineering
Lexis takes the privilege to invite speakers, participants, students, delegates and exhibitors from across the globe to its premier Auto Mech 2019, to be held during Oct 23-24, 2019, at Tokyo, Japan. This revered conference will be focusing on the theme “Evolving with the current innovative research in Mechanical and Automotive Engineering”. Lexis takes the privilege to invite speakers, participants, students, delegates and exhibitors from across the globe to its premier
Global Alzheimer’s disease, Dementia and Ageing Awareness
Lexis brings in a new spin on conferences by presenting the latest scientific improvements in the fields of Neurology and Neuroscience. Zurich is all set for an amazing event as LEXIS proudly presents the “Global Alzheimers, Dementia and Ageing Awareness” slated on July 17-18, 2019 at Zurich, Switzerland. The theme of the conference is “Global Voice and Awareness on Alzheimers Disease and Dementia Care”. Avenue Roger VAndendriessche, 18 at 1150 BRUSSELS Avenue

All 5 Releases


More Releases for Lung

Interstitial Lung Disease Therapeutics - Pipeline Analysis 2018
Interstitial lung disease is a type of inflammatory disease that affects and thickens the interstitium of the lungs. Download the sample report @ https://www.pharmaproff.com/request-sample/1126 The interstitium is a lace like network of the tissue that provide support to the air sacs and the capillaries in the interstitium which allows the gas exchange between the blood and alveolar tissues. Get the detailed analysis @ https://www.pharmaproff.com/report/interstitial-lung-disease-therapeutics-pipeline-analysis Some of the types of the condition include
Lung Cancer Surgery Market Forecasts (2016-2021)
Lung Cancer Surgery Market was worth USD 21.58 billion in 2016 and is expected to reach USD 30.32 billion by 2021 with a CAGR of 6.92 %. Lung Cancer is a type of Cancer that starts in Trachea, Bronchus or lung Tissue. They are many ways to treat Lung Cancer. Some of them are Chemotherapy, Radiotherapy, Laser therapy, and Surgery. Surgery involves removal of infected section from lungs. There are many
Acute Lung Injury Market Technological breakthroughs 2025
Acute lung injury (ALI) is commonly characterized by hypoxia, lung complication and pulmonary edema. This condition causes inflammation or direct injury to the lungs. Generally, the symptoms of this disease are divided into two forms namely, primary ALI and secondary ALI. Primary ALI is caused by the conditions like pneumonia. While, secondary ALI is mainly caused by indirect injury to the lungs. Inhalation injury, pulmonary contusions, sever trauma, shock are
Lung Cancer Treatment Market Outlook to 2022
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions The global lung cancer drugs market was valued at $3.1bn in 2016 and is forecast to grow at a healthy 31.1% CAGR between 2016
Europe Lung Cancer Drug Pipeline Analysis
The most common type of cancer in terms of incidence and mortality rate is Lung cancer. Lung cancer is a disease in which the lining of the cell of the lung tissue has an uncontrollable growth which in turn leads to the formation of tumor. There are two main types of lung cancer; small cell lung cancer which accounts for about 20% and non-small cell lung cancer (NSCLC) that accounts
04-28-2017 | Health & Medicine
TMR
Lung Cancer Therapeutics Market Research Report 2017
Abnormal cell growth can lead to cancer. Cells that grow uncontrollably invade nearby tissues and further spread to other parts of the body through the lymphatic system. Lung cancer, also known as lung carcinoma, is characterized by uncontrolled cell growth in lungs. There are three major types of lung cancer: non-small cell lung cancer, small cell lung cancer, and lung carcinoid tumor. Non-small cell lung cancer is the common type